NAMS: NewAmsterdam Pharma Company N.V.
Performance
NAMS -48.31%
Watchlist
Select an item
Summary
NAMS at a glance
NAMS returned -48.31% over the past year. Its worst drop in that year was -54.43%, smaller than 17% of stocks on Redstone, and its Sharpe ratio of -1.03 beats 4% of stocks on Redstone. It pays no dividends.
Current Drawdown
-54.16%
Rolling Volatility
63.43%
Actions
Metrics
Risk Indicators
Alpha-69.68%
Beta1.44x
Sharpe-1.03
Sortino-1.41
Omega0.85
Calmar-0.89
Martin-1.92
Profile
About NAMS
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $2.3B
- Listed
- Nov 2022
- Employees
- 100
- Headquarters
- Narrden, P7
- Website
- newamsterdampharma.com
Comparisons